Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate the efficacy of an educational seminar series for women with vulvar vestibulitis syndrome (VVS).


Clinical Trial Description

HYPOTHESIS: It is hypothesized that this educational seminar series might be effective in reducing the pain experienced and improving sexual response and quality of life of women with Vulvar Vestibulitis Syndrome (VVS) by providing an open forum for discussion of the pathology, etiological theories, treatment plans as well as the impact of sexual pain on sexual relationships and ways to cope with VVS.

At Vancouver Hospital, the current waitlist for women with distressing, unremitting genital pain is approximately 10 months. Once accepted for management, the diagnosis of VVS is given, where applicable, by Dr. Sadownik. Only women with pure VVS and without a compounding skin condition are then referred on to the 3-session educational seminars given by Dr. Thomson. By the end of the educational series, women have an understanding of current scientific literature on etiology and treatment of VVS, and it's interaction with sexual health factors. At this point they are referred for individualized treatment of the VVS either by Dr. Thomson, Dr. Sadownik or back to their referring physician. This study aims to explore the existing VVS Educational Seminars by measuring sexual function, sexual distress, pain levels (general pain, genital pain and pain upon sexual activity), psychological well-being (depression and anxiety), relationship satisfaction, sexual knowledge and overall quality of life at pre- and post seminar. An age-matched control group of women diagnosed with VVS, but unable to attend the Seminar series, will complete the measures at the same intervals as the treatment group. The use of the control group allows us to accurately evaluate the efficacy of the Educational seminars, above and beyond non-specific factors.

Vulvar Vestibulitis Syndrome Educational Seminars have been run through the Vulvar Disease Clinic at Vancouver Hospital since 2001, however no data has been collected to determine the effects of this program. By collecting pre- & post seminar and follow up data, this study will allow us to assess the efficacy of the VVS Educational Seminars when compared to a group of women suffering from VVS but unable to attend the information seminars. Given that a large proportion of the women cannot be treated at Vancouver Hospital and are instead referred back to their family physician, the VVS Educational Seminar is a necessary first step in the treatment process for ensuring that women receive accurate and timely treatment. It will also help treatment providers improve and expand their current treatment practices ;


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00278850
Study type Observational
Source University of British Columbia
Contact
Status Completed
Phase N/A
Start date January 2006
Completion date March 2009

See also
  Status Clinical Trial Phase
Completed NCT05478746 - Effects of Flourish HEC on Localized Provoked Vulvodynia N/A
Completed NCT02494934 - Effectiveness of Cognitive Behavioural Therapy and Physical Therapy for Provoked Vestibulodynia N/A
Completed NCT01996384 - Provoked, Localized Vulvodynia Treatment With Acupuncture and Lidocaine Pilot Study Phase 1
Completed NCT00501774 - A Search for Helicobacter Pylori in Localized Vulvodynia N/A
Not yet recruiting NCT02393911 - Dysbiosis in Localized Provoked Vulvodynia (LPV) Phase 3
Completed NCT02204319 - Cold Laser: A Modality to Promote Vulvar Healing and Pain Relief N/A
Recruiting NCT03481621 - Effect of Two Acupuncture Protocols on Vulvodynia N/A
Completed NCT02704234 - Acupuncture for Vulvodynia: A Pre-pilot Study N/A
Completed NCT03364127 - Effect of Acupuncture on Patient Vulvodynia Outcomes N/A
Completed NCT02197429 - Acupuncture for the Treatment of Vulvodynia N/A
Terminated NCT00853229 - Pregabalin for the Treatment of Vulvodynia Phase 2
Terminated NCT00450242 - 5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis Phase 2
Recruiting NCT00119886 - Botox on Vulvar Vestibulitis Phase 4